An observational study of the association between microalbuminuria and increased N-terminal pro-B-type natriuretic peptide in patients with subarachnoid hemorrhage

被引:3
|
作者
Terao Y. [1 ]
Oji M. [1 ]
Toyoda T. [1 ]
Inoue H. [1 ]
Fukusaki M. [1 ]
Hara T. [2 ]
机构
[1] Nagasaki Rosai Hospital, Department of Anesthesia, 2-12-5 Setogoe, Sasebo
[2] Nagasaki University School of Medicine, Department of Anesthesiology, 1-7-1 Sakamoto, Nagasaki
关键词
B-type natriuretic peptide; Microalbuminuria; N-terminal pro-B-type natriuretic peptide; Neurological outcome; Subarachnoid hemorrhage;
D O I
10.1186/s40560-015-0108-1
中图分类号
学科分类号
摘要
Background: The urinary albumin/creatinine ratio (ACR) is a significant neurologic prognostic predictor in patients with aneurysmal subarachnoid hemorrhage (SAH). B-type natriuretic peptide (BNP) plays an important role in body fluid regulation in patients with SAH. The present study was performed to determine whether ACR was independent predictor for unfavorable neurological outcome and ACR was associated with increased N-terminal pro-BNP (NT-pro-BNP) after SAH. Methods: We studied 61 patients undergoing surgery who were admitted within 48 h after aneurysmal SAH onset between July 2008 and June 2010. Hunt and Hess grade and Fisher grade were recorded at admission. The Glasgow Coma Scale (GCS) score was calculated at admission and daily for seven postoperative days. Arterial blood was sampled at admission and for seven postoperative days to determine the PaO2/FIO2 ratio, C-reactive protein level, troponin I level, and NT-pro-BNP level. Urine was sampled at admission and daily for seven postoperative days to determine ACR and vanillylmandelic acid/creatinine ratio (VMACR). Neurological outcomes were assessed at hospital discharge by using the Glasgow Outcome Scale. Receiver operating characteristic curves were constructed for the predictive variables of unfavorable neurological outcomes, and the area under the curve (AUC) was determined. Multivariate logistic regression analyses were performed for the significant predictors of unfavorable neurological outcomes after SAH. Associations with NT-pro-BNP were evaluated by using the Spearman rank correlation test. Results: Of the 61 patients, 24 had unfavorable outcomes. The prevalence rate of microalbuminuria was 85 % (52/61). The highest NT-pro-BNP levels were above the normal range in 57 of 61 patients (93 %). According to the AUC, the Hunt and Hess grade, GCS score, the highest ACR, and highest VMACR were significant predictors of neurological outcome. Multivariate logistic regression analyses showed that the highest ACR and Hunt and Hess grade are independent prognostic predictors of unfavorable neurological outcomes. The highest NT-pro-BNP significantly correlated with the highest troponin I, highest ACR, and VMACR on admission. Conclusions: The highest ACR is an independent prognostic predictor of unfavorable neurological outcomes after SAH. Moreover, plasma NT-pro-BNP elevation may be associated with the development of microalbuminuria. © 2015 Terao et al.
引用
收藏
相关论文
共 50 条
  • [41] N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity
    Mangge, Harald
    Almer, Gunter
    Zelzer, Sieglinde
    Vasan, Ramachandran
    Kraigher-Krainer, Elisabeth
    Gasser, Robert
    Schnedl, Wolfgang
    Ille, Rottraut
    Wallner, Sandra
    Moeller, Reinhard
    Horejsi, Renate
    Weghuber, Daniel
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (09) : 1539 - 1545
  • [42] N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations
    Waltraut M. Merz
    Kirsten Kübler
    Eike Albers
    Birgit Stoffel-Wagner
    Ulrich Gembruch
    Clinical Research in Cardiology, 2012, 101 : 73 - 79
  • [43] N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations
    Merz, Waltraut M.
    Kuebler, Kirsten
    Albers, Eike
    Stoffel-Wagner, Birgit
    Gembruch, Ulrich
    CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (02) : 73 - 79
  • [44] N-terminal pro-B-type natriuretic peptide levels in systolic heart failure
    Hamdi, I.
    Mahfoudhi, H.
    Ben Mansour, N.
    Mazni, F.
    Dahmani, R.
    Lahidheb, D.
    Fehri, W.
    Haouala, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 79 - 79
  • [45] Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome
    Thomas Stiermaier
    Francesco Santoro
    Tobias Graf
    Francesca Guastafierro
    Nicola Tarantino
    Luisa De Gennaro
    Pasquale Caldarola
    Matteo Di Biase
    Holger Thiele
    Natale D. Brunetti
    Christian Möller
    Ingo Eitel
    Clinical Research in Cardiology, 2018, 107 : 597 - 606
  • [46] Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome
    Stiermaier, Thomas
    Santoro, Francesco
    Graf, Tobias
    Guastafierro, Francesca
    Tarantino, Nicola
    De Gennaro, Luisa
    Caldarola, Pasquale
    Di Biase, Matteo
    Thiele, Holger
    Brunetti, Natale D.
    Moeller, Christian
    Eitel, Ingo
    CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (07) : 597 - 606
  • [47] High N-Terminal Pro-B-Type Natriuretic Peptide: A Biomarker of Lung Cancer?
    Aujollet, Nathalie
    Meyer, Marjorie
    Cailliod, Romain
    Combier, Fanny
    Coignet, Yann
    Campard, Sebastien
    Facy, Olivier
    Bernard, Alain
    Girard, Claude
    CLINICAL LUNG CANCER, 2010, 11 (05) : 341 - 345
  • [48] N-Terminal Pro-B-Type Natriuretic Peptide Predicts the Burden of Pulmonary Embolism
    Luis Alonso-Martinez, Jose
    Urbieta-Echezarreta, Miren
    Javier Anniccherico-Sanchez, Francisco
    Luisa Abinzano-Guillen, Maria
    Luis Garcia-Sanchotena, Jose
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2009, 337 (02): : 88 - 92
  • [49] Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
    Ribeiro, Demostenes G. L.
    Silva, Ricardo P.
    Barboza, Daniella R. M. M.
    Lima-Junior, Roberto C. P.
    Ribeiro, Ronaldo A.
    CLINICS, 2014, 69 (06) : 405 - 412
  • [50] N-terminal pro-B-type natriuretic peptide and mortality in coronary heart disease
    Pöge, U
    Gerhardt, TM
    Woitas, RP
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19): : 2025 - 2025